foxo4 dri senolytic FOXO4-DRI: The Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness The FOXO4 peptide in a
The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI 10mg Senolytic Research Peptide Kalyx Labs Molecular targets of senolytic drugs. Download Scientific Diagram
Pay in 4 interest-free payments of $7.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


